This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Mercian Corporation, Sanraku Incorporated, Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1990-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1990-1996
Title: The Innovations of Kaichiro Kominato
Introduction
Kaichiro Kominato is a notable inventor based in Yamato, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds useful for treating circulatory diseases. With a total of 4 patents to his name, his work continues to impact the medical community.
Latest Patents
Kominato's latest patents include the innovative 3,4'-dideoxymycaminosltylonolide derivative and a process for producing 4-hydroxypyridine derivatives. These derivatives are particularly useful for treating circulatory diseases. One of the key patents describes a 4-hydroxypyridine derivative represented by a specific formula, wherein R can be a methyl group or an isopropyl group. The method for preparing this derivative involves cultivating a strain belonging to Streptomyces karnatakensis. Additionally, the patents disclose a pharmaceutical composition comprising the same and a method for treating circulatory diseases by administering the compound to a patient.
Career Highlights
Throughout his career, Kominato has worked with various organizations, including Mercian Corporation and Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. His experience in these companies has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.
Collaborations
Kominato has collaborated with notable coworkers such as Takeo Yoshioka and Hiroshi Tone. Their combined expertise has fostered an environment of innovation and creativity in their projects.
Conclusion
Kaichiro Kominato's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in treatments for circulatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile